Concordance Analysis for Qualitative Assays

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

• Choose Cohen's kappa when both your new qualitative assay and the reference method produce binary or categorical results and you need to measure agreement beyond chance.
• Use weighted kappa when your assay categories have a natural order, such as negative, equivocal, and positive, because it penalizes larger disagreements more heavily.
• Apply McNemar's test to determine whether disagreement between the two methods is systematic, meaning one method consistently classifies samples as positive while the other does not.

At a Glance

The table below summarizes the primary statistical tools for concordance analysis in qualitative assay validation. Each test answers a different question about the relationship between your new assay and a reference method.

Understanding Concordance in Qualitative Assay Validation

Qualitative assays report a categorical outcome, such as positive or negative, instead of a continuous numerical value. When you introduce a new qualitative assay into a laboratory, you must demonstrate that it produces results consistent with an established reference method. This process, called concordance analysis, quantifies how often the two methods agree and characterizes the nature of any disagreement.

The statistical foundation for concordance analysis rests on comparing paired observations. Each clinical sample or reference material is tested by both the new assay and the reference method, producing a pair of results. The pattern of agreement and disagreement across all paired results forms the basis for calculating agreement statistics.

Concordance analysis serves a different purpose than analytical sensitivity or specificity. Analytical sensitivity describes the smallest amount of analyte the assay can detect. Analytical specificity describes the ability of the assay to measure only the intended analyte without interference. Concordance analysis instead asks whether the new assay produces the same classification as the reference method across a range of samples. These concepts are related but distinct, and a validation plan should address each separately.

The choice of statistical test depends on the structure of your data. If both methods produce two categories, Cohen's kappa is appropriate. If the categories have a natural order, weighted kappa accounts for the severity of disagreement. If you need to understand whether one method is systematically biased toward a particular result, McNemar's test provides that information.

Laboratory professionals should also recognize that concordance analysis is part of a broader validation framework. The National Institute of Standards and Technology emphasizes that measurement science depends on standards, calibration, and quality practices that support reliable results. Your concordance analysis should be documented within this larger quality system, with clear protocols for sample handling, data collection, and statistical interpretation.

Selecting the Appropriate Statistical Test

The choice of statistical test is a decision that should be made during the validation planning phase, not after data collection. The decision depends on the nature of your assay categories and the specific question you need to answer.

Cohen's Kappa for Binary Outcomes

Cohen's kappa is the most widely used statistic for measuring agreement between two methods that each produce two categories. The statistic compares the observed agreement with the agreement that would be expected by chance alone. A kappa value of 1 indicates perfect agreement, a value of 0 indicates agreement no better than chance, and negative values indicate agreement worse than chance.

The calculation begins with a two-by-two contingency table. Each cell contains the number of samples that fall into one of four categories: both methods positive, both negative, new assay positive with reference negative, or new assay negative with reference positive. The observed agreement is the proportion of samples where both methods agree. The expected agreement is calculated from the marginal totals of the table, representing the agreement that would occur if the two methods were independent.

Cohen's kappa is appropriate when your assay produces two categories and the reference method also produces two categories. The statistic does not require the categories to be ordered, and it does not assume that one method is the gold standard. It simply measures the degree of agreement between the two methods.

The interpretation of kappa values follows a widely used convention. Values below 0.20 indicate slight agreement, values from 0.21 to 0.40 indicate fair agreement, values from 0.41 to 0.60 indicate moderate agreement, values from 0.61 to 0.80 indicate substantial agreement, and values above 0.81 indicate almost perfect agreement. These thresholds are interpretive guidelines instead of regulatory requirements, and the acceptable threshold for your validation should be defined in your validation protocol.

Weighted Kappa for Ordered Categories

Some qualitative assays produce more than two categories, and those categories may have a natural order. A common example is a result reported as negative, equivocal, or positive. In this situation, a disagreement between negative and equivocal is less serious than a disagreement between negative and positive. Weighted kappa accounts for this difference.

Weighted kappa assigns a weight to each possible disagreement. A weight of 1 indicates full agreement, and weights decrease as the disagreement becomes more serious. The most common weighting schemes are linear and quadratic. Linear weighting assigns weights that decrease proportionally with the distance between categories. Quadratic weighting assigns weights that decrease with the square of the distance, which penalizes large disagreements more heavily.

The choice of weighting scheme should be made before data collection and documented in the validation protocol. Different weighting schemes can produce different kappa values for the same data, so the scheme must be justified and consistent with the clinical or analytical importance of the categories.

Weighted kappa is appropriate when the categories have a meaningful order and when the consequences of disagreement differ across category pairs. If the categories are truly nominal, such as different pathogen types with no natural order, weighted kappa is not appropriate.

McNemar's Test for Systematic Disagreement

McNemar's test addresses a different question from kappa. While kappa measures the overall agreement, McNemar's test determines whether the disagreements between the two methods are balanced or whether one method is systematically more likely to produce a particular result.

The test uses the two cells of the contingency table that represent disagreement. One cell contains samples where the new assay is positive and the reference is negative. The other cell contains samples where the new assay is negative and the reference is positive. McNemar's test compares these two counts to determine whether the disagreement is symmetric.

A significant McNemar's test result indicates that the disagreement is not symmetric. For example, if the new assay produces many more positive results than the reference method, the test will detect this systematic bias. This information is valuable because it suggests a problem with the new assay, such as a threshold that is set too low or a reagent that is producing false positives.

McNemar's test is appropriate when you have paired data and you need to understand the direction of disagreement. The test does not measure the magnitude of agreement, so it should be used alongside kappa instead of as a replacement.

Building a Decision Tree for Test Selection

The selection of the appropriate statistical test can be organized as a decision tree. The first question is whether your data are categorical. If the assay produces a continuous value that is later dichotomized, the analysis should account for the threshold selection process.

The second question is whether the categories are ordered. If the categories are not ordered, Cohen's kappa is appropriate. If the categories are ordered, weighted kappa is appropriate.

The third question is whether you need to understand the direction of disagreement. If you need to know whether one method is systematically biased, McNemar's test provides this information.

The decision tree below summarizes this process.

flowchart TD
    A[Do both methods produce categorical results?] -->|No| B[Consider quantitative agreement methods]
    A -->|Yes| C[Are the categories ordered?]
    C -->|No| D[Use Cohen's kappa]
    C -->|Yes| E[Use weighted kappa]
    D --> F[Do you need to assess systematic bias?]
    E --> F
    F -->|Yes| G[Add McNemar's test]
    F -->|No| H[Report kappa with confidence interval]

The decision tree is a planning tool. The choice of test should be documented in the validation protocol before data collection begins. Changing the statistical test after viewing the data can lead to biased conclusions.

Practical Workflow for Concordance Analysis

A concordance analysis should follow a structured workflow that begins with protocol development and ends with a documented report. The workflow below describes the steps that a validation scientist should follow.

Step 1: Define the Validation Protocol

The validation protocol should specify the reference method, the new assay, the sample set, the statistical tests, and the acceptance criteria. The protocol should be written before data collection begins and should be approved by the laboratory supervisor or quality manager.

The protocol should also specify the sample size. The sample size should be large enough to provide a stable estimate of kappa. A small sample size produces a wide confidence interval, which makes it difficult to determine whether the agreement is acceptable. The sample size calculation should account for the expected prevalence of the condition and the expected agreement between the methods.

Step 2: Collect Paired Data

Each sample should be tested by both the new assay and the reference method. The samples should be tested under the same conditions, and the order of testing should be randomized to avoid bias. The person performing the assay should be blinded to the reference result when possible.

The samples should represent the range of results that the assay will encounter in practice. This includes samples that are clearly positive, clearly negative, and samples near the threshold of detection. A sample set that contains only strongly positive and clearly negative samples will produce a higher kappa than a sample set that includes borderline samples.

Step 3: Construct the Contingency Table

The paired results should be organized into a contingency table. The rows represent the new assay result, and the columns represent the reference result. Each cell contains the number of samples with that combination of results.

The contingency table is the foundation for all subsequent statistical calculations. The table should be checked for accuracy before any calculations are performed.

Step 4: Calculate the Agreement Statistics

The kappa statistic, weighted kappa, and McNemar's test should be calculated according to the protocol. The calculations can be performed using statistical software or by hand for small data sets.

The kappa statistic should be reported with its confidence interval. The confidence interval provides a range of plausible values for the true kappa, and it is more informative than the point estimate alone.

Step 5: Interpret the Results

The results should be interpreted in the context of the acceptance criteria defined in the protocol. If the kappa value meets the acceptance criterion, the new assay is considered to have acceptable agreement with the reference method. If the kappa value is below the acceptance criterion, the validation has failed, and the assay should be investigated.

The McNemar's test result should be interpreted in the context of the disagreement pattern. A significant McNemar's test indicates a systematic bias, which should be investigated even if the kappa value is acceptable.

Step 6: Document the Results

The validation report should include the contingency table, the statistical calculations, the confidence intervals, and the interpretation. The report should also include the protocol, the sample description, and any deviations from the protocol.

The report should be stored in the laboratory quality system and should be available for inspection by regulatory authorities or accreditation bodies.

Records and Measurements

The records from a concordance analysis should be complete enough to allow another scientist to reproduce the analysis. The following records should be maintained.

Sample Tracking Records

Each sample should have a unique identifier. The identifier should be linked to the sample source, the date of collection, and the date of testing. The sample tracking records should allow the laboratory to trace any result back to the original sample.

Assay Results

The raw results from the new assay and the reference method should be recorded. The results should include the date of testing, the operator, the instrument, and the reagent lot numbers. This information is important for investigating any discrepancies.

Statistical Calculations

The statistical calculations should be documented, including the contingency table, the kappa calculation, and the confidence interval. The calculations should be reproducible from the raw data.

Deviation Records

Any deviation from the validation protocol should be documented. The deviation record should describe the deviation, the reason for the deviation, and the impact on the validation results.

Common Failure Patterns in Concordance Analysis

Several common failure patterns can compromise a concordance analysis. Recognizing these patterns can help you avoid them or correct them before they invalidate the results.

Inadequate Sample Size

A sample size that is too small produces a kappa estimate with a wide confidence interval. The confidence interval may include values that are both acceptable and unacceptable, making it impossible to conclude that the agreement is adequate. The sample size should be calculated during the protocol development phase.

Sample Selection Bias

If the sample set contains only clearly positive and clearly negative samples, the kappa will be higher than it would be with a sample set that includes borderline samples. The sample set should reflect the range of results that the assay will encounter in practice.

Unblinded Testing

If the operator knows the reference result before performing the new assay, the operator may be influenced by that knowledge. The testing should be blinded to prevent this bias.

Inappropriate Test Selection

Using Cohen's kappa for ordered categories or using McNemar's test as a measure of agreement are common errors. The test should be selected based on the data structure and the question being asked.

Misinterpretation of Kappa Values

The kappa value is a measure of agreement beyond chance, but it is not a measure of the clinical utility of the assay. A high kappa does not guarantee that the assay is clinically useful, and a low kappa does not necessarily mean the assay is useless. The kappa value should be interpreted in the context of the assay's purpose and the prevalence of the condition.

Limitations of Concordance Statistics

Concordance statistics have limitations that should be acknowledged in the validation report.

Kappa Is Prevalence Dependent

The kappa statistic is influenced by the prevalence of the condition in the sample set. If the prevalence is very low or very high, the kappa value will be lower than it would be for a sample set with a more balanced prevalence. This means that kappa values from different studies are not directly comparable unless the prevalence is similar.

Kappa Does Not Indicate the Direction of Disagreement

Kappa measures the magnitude of agreement but does not indicate whether the disagreement is systematic. Two studies with the same kappa value can have very different patterns of disagreement. McNemar's test should be used to assess the direction of disagreement.

Weighted Kappa Depends on the Weighting Scheme

The weighted kappa value depends on the weighting scheme that is chosen. Different weighting schemes can produce different kappa values for the same data. The weighting scheme should be justified and documented.

McNemar's Test Does Not Measure Agreement

McNemar's test is a test of the symmetry of disagreement, not a measure of agreement. A significant McNemar's test indicates a systematic bias, but it does not indicate the magnitude of the bias.

Quality Controls and Standards

The concordance analysis should be conducted within a quality system that follows established standards. The National Institute of Standards and Technology provides guidance on measurement science, standards, and calibration that is relevant to laboratory quality. The laboratory should have documented procedures for instrument calibration, reagent handling, and data management.

The quality system should include internal quality controls, such as positive and negative controls, that are run with each batch of samples. The controls should be tested with both the new assay and the reference method to ensure that the methods are performing correctly.

The quality system should also include external quality assessment, such as participation in proficiency testing programs. Proficiency testing provides an independent assessment of the laboratory's performance and can identify systematic errors that are not apparent from internal controls.

Biosafety and Regulatory Context

The concordance analysis may involve the use of biological samples that pose a risk to laboratory workers. The Biosafety in Microbiological and Biomedical Laboratories manual provides principles for biosafety, risk assessment, and containment. The laboratory should conduct a risk assessment before beginning the validation and should follow the appropriate biosafety level for the samples being tested.

The risk assessment should consider the nature of the samples, the procedures being performed, and the potential for exposure. The laboratory should implement the appropriate containment measures, including personal protective equipment, engineering controls, and administrative controls.

If the assay involves recombinant or synthetic nucleic acid molecules, the laboratory should follow the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. These guidelines provide oversight for research involving these molecules and should be followed when applicable.

The laboratory should also follow the protocols for the specific assay being validated. The Addgene protocols provide educational context for molecular biology workflows, but they should not be treated as universally validated protocols. The laboratory should validate the specific protocol for its own conditions.

Reporting and Documentation Standards

The reporting of a concordance analysis should follow the standards for transparency and completeness. The MIQE guidelines provide a framework for reporting qPCR experiments, and the principles of transparency and completeness apply to concordance analysis as well.

The report should include the following elements:

• The purpose of the validation
• The description of the new assay and the reference method
• The sample description, including the sample source and the sample size
• The contingency table
• The statistical calculations, including the kappa value, the confidence interval, and the McNemar's test result
• The interpretation of the results
• The limitations of the analysis

The report should be written in a way that allows another scientist to understand the analysis and to reproduce it if necessary.

Professional Escalation Criteria

The validation scientist should escalate the following situations to the laboratory supervisor or quality manager:

• The kappa value is below the acceptance criterion defined in the protocol
• The McNemar's test indicates a systematic bias that cannot be explained by the assay design
• The sample size is too small to provide a meaningful confidence interval
• The data quality is compromised by a deviation from the protocol
• The results are inconsistent with the expected performance of the assay

The escalation should include a description of the problem, the data that support the concern, and the proposed next steps.

Building a Concordance Analysis Work Plan with Prespecified Acceptance Criteria

A concordance analysis is only as defensible as the plan that precedes it. Many validation projects fail not because the statistics are wrong but because the acceptance criteria were vague, the sample set was assembled without a target prevalence, or the disagreement pattern was never examined before the kappa value was calculated. This section provides a practical decision framework that connects the statistical tests to a documented work plan, a structured record system, and a troubleshooting method for disagreement patterns.

Define the Analysis Objective Before Data Collection

The first decision in any concordance analysis is not which statistic to calculate. The first decision is what question the analysis must answer. Write this question in the validation protocol as a single sentence. For example, the objective might be stated as "determine whether the new assay classifies clinical samples as positive or negative in agreement with the reference method at a level that supports clinical use." This objective statement drives every subsequent decision.

The objective determines the data structure. If the objective is to measure overall agreement, Cohen's kappa is the primary statistic. If the objective is to measure agreement with ordered categories, weighted kappa is the primary statistic. If the objective is to detect a systematic bias, McNemar's test is the primary statistic. Many validation protocols need more than one statistic because they need to answer more than one question. The protocol should state which statistic is primary and which are secondary.

The objective also determines the sample set. A concordance analysis for a screening assay that will be used in a low-prevalence population requires a different sample set than a confirmatory assay used in a high-prevalence population. The sample set should reflect the intended use of the assay, beyond the convenience of available samples.

Define Acceptance Criteria in the Protocol

Acceptance criteria are the numerical thresholds that determine whether the validation passes or fails. These criteria must be written in the protocol before data collection begins. The criteria should include the minimum acceptable kappa value, the maximum acceptable confidence interval width, and the maximum acceptable proportion of discordant pairs.

The kappa acceptance criterion should be based on the intended use of the assay. An assay used for screening may require a lower kappa than an assay used for confirmation. The criterion should be justified in the protocol with a brief explanation of the clinical or analytical consequences of a wrong result.

The confidence interval criterion is often overlooked. A kappa point estimate of 0.85 is meaningless if the confidence interval spans from 0.40 to 0.99. The protocol should specify the maximum acceptable confidence interval width. This criterion is directly tied to the sample size. A larger sample produces a narrower confidence interval, so the sample size calculation should be based on the desired confidence interval width.

The discordance criterion addresses the pattern of disagreement. The protocol should specify the maximum acceptable proportion of discordant pairs in each direction. For example, the protocol might state that no more than 5 percent of samples may be positive by the new assay and negative by the reference method. This criterion is separate from the kappa criterion because a high kappa can still hide a clinically important systematic bias.

Sample Size Planning for a Stable Kappa Estimate

The sample size for a concordance analysis is determined by the expected kappa value, the expected prevalence of the condition, and the desired confidence interval width. The sample size calculation should be performed during the protocol development phase and documented in the protocol.

A common mistake is to use a sample size that is adequate for detecting a difference in proportions but inadequate for estimating kappa with precision. The kappa statistic has a larger standard error than a simple proportion, so the sample size must be larger than the sample size for a proportion-based analysis.

The sample size calculation should also account for the expected prevalence. If the prevalence is expected to be low, the sample size must be larger to ensure that enough positive samples are included. A sample set with only 5% positive samples will produce a kappa estimate with a wide confidence interval unless the sample size is very large.

The protocol should also specify the minimum number of samples in each cell of the contingency table. A common rule is that each cell should have at least five samples for the kappa calculation to be stable. If any cell has fewer than five samples, the kappa estimate should be interpreted with caution, and the confidence interval should be reported.

Assembling the Sample Set with a Target Prevalence

The sample set should be assembled with a target prevalence in mind. The target prevalence should reflect the population in which the assay will be used. If the assay will be used in a population with a 20% prevalence of the condition, the sample set should contain approximately 20% positive samples.

The sample set should also include samples that span the range of results the assay will encounter. This includes samples that are clearly positive, clearly negative, and samples near the threshold of detection. A sample set that contains only clearly positive and clearly negative samples will produce a kappa value that is higher than the kappa value that would be obtained in practice.

The sample set should be assembled from a source that is independent of the assay being validated. If the samples are selected because they are known to be positive or negative, the selection process should be documented. The protocol should describe the sample source, the inclusion criteria, and the exclusion criteria.

The sample set should also include samples that are known to be difficult to classify. These samples might include samples with low analyte concentration, samples with interfering substances, or samples from patients with conditions that produce cross-reactivity. These samples are important because they test the assay under realistic conditions.

The Paired Testing Protocol

Each sample must be tested by both the new assay and the reference method. The testing should be performed under the same conditions, and the order of testing should be randomized to avoid bias. The operator should be blinded to the reference result when performing the new assay.

The protocol should specify the time between the two tests. If the sample is unstable, the two tests should be performed as close together as possible. The protocol should also specify the storage conditions for the samples between the two tests.

The protocol should specify the number of replicates for each sample. A single replicate is common for a concordance analysis, but multiple replicates can be used to assess the repeatability of the assay. If multiple replicates are used, the analysis should account for the correlation between replicates.

The Disagreement Investigation Method

When the contingency table shows a pattern of disagreement, the validation scientist should investigate the cause before deciding whether the assay is acceptable. The investigation should follow a structured method that examines the samples, the assay, and the reference method.

The first step is to examine the discordant samples. The samples that are positive by the new assay and negative by the reference method should be examined for a common characteristic. The samples that are negative by the new assay and positive by the reference method should be examined separately. The examination should include the sample source, the sample collection date, the sample storage conditions, and the sample matrix.

The second step is to examine the assay records. The discordant samples should be checked for the reagent lot, the instrument, the operator, and the date of testing. A pattern of discordance that is associated with a specific reagent lot or instrument suggests a technical problem.

The third step is to examine the reference method. The reference method may have its own limitations. The reference method may be less sensitive than the new assay, or it may be more sensitive. The reference method may also have a different threshold for positivity.

The fourth step is to consider the biological basis for the discordance. The new assay may detect a different target than the reference method. The new assay may detect a different strain or a different subtype. The new assay may detect the target at a different stage of the infection.

The investigation should be documented in the validation report. The report should describe the discordant samples, the investigation steps, and the conclusion. The conclusion should state whether the discordance is explained by a technical problem, a biological difference, or a limitation of the reference method.

The Decision Matrix for Discordance Resolution

The decision matrix below provides a structured approach to resolving discordance. The matrix uses the discordance pattern and the investigation findings to determine the next step.

The decision matrix is a planning tool. The validation protocol should specify the decision matrix before data collection begins. The protocol should also specify the escalation criteria for each decision.

The Record System for Concordance Analysis

The record system for a concordance analysis should be designed to support the investigation of discordance. The records should allow the validation scientist to trace any result back to the sample, the operator, the instrument, and the reagent lot.

The sample tracking record should include the unique sample identifier, the sample source, the sample collection date, the sample matrix, and the sample storage conditions. The sample tracking record should also include the date of testing for each assay.

The assay record should include the operator name, the instrument identifier, the reagent lot number, the calibration status, and the quality control results. The assay record should also include the raw result and the interpreted result.

The statistical record should include the contingency table, the kappa calculation, the confidence interval, and the McNemar's test result. The statistical record should also include the software used for the calculation and the version of the software.

The deviation record should include any deviation from the protocol. The deviation record should describe the deviation, the reason for the deviation, and the impact on the validation results.

The Concordance Report Structure

The concordance report should be structured to allow another scientist to reproduce the analysis. The report should include the following sections:

• The objective of the analysis
• The description of the new assay and the reference method
• The sample description, including the sample source, the sample size, and the target prevalence
• The contingency table
• The statistical calculations, including the kappa value, the confidence interval, and the McNemar's test result
• The discordance investigation
• The interpretation of the results
• The limitations of the analysis

The report should be written in a way that allows another scientist to understand the analysis and to reproduce it if necessary. The report should be stored in the laboratory quality system and should be available for inspection by regulatory authorities or accreditation bodies.

Common Failure Patterns in the Work Plan

Several common failure patterns can compromise a concordance analysis. Recognizing these patterns can help you avoid them or correct them before they invalidate the results.

The first failure pattern is the absence of a prespecified acceptance criterion. If the acceptance criterion is defined after the data is collected, the validation is biased. The criterion should be defined in the protocol before data collection begins.

The second failure pattern is the use of a sample set that does not reflect the target prevalence. If the sample set contains a higher prevalence than the target population, the kappa value will be higher than the kappa value that would be obtained in practice.

The third failure pattern is the failure to investigate discordance. If the discordance is not investigated, the validation may pass even though the assay has a systematic bias. The discordance investigation should be a required step in the validation workflow.

The fourth failure pattern is the use of a sample size that is too small. A small sample size produces a kappa estimate with a wide confidence interval. The confidence interval may include values that are both acceptable and unacceptable, making it impossible to conclude that the agreement is adequate.

The fifth failure pattern is the failure to document the analysis. If the analysis is not documented, the validation cannot be reproduced. The documentation should be complete enough to allow another scientist to reproduce the analysis.

Professional Escalation Criteria

The validation scientist should escalate the following situations to the laboratory supervisor or quality manager:

• The kappa value is below the acceptance criterion defined in the protocol
• The confidence interval width exceeds the maximum acceptable width defined in the protocol
• The McNemar's test indicates a systematic bias that cannot be explained by the assay design
• The discordance investigation identifies a technical problem that cannot be resolved
• The sample size is too small to provide a meaningful confidence interval
• The data quality is compromised by a deviation from the protocol

The escalation should include a description of the problem, the data that support the concern, and the proposed next steps. The escalation should be documented in the validation report.

The Role of Quality Controls in Concordance Analysis

The concordance analysis should be conducted within a quality system that follows established standards. The National Institute of Standards and Technology provides guidance on measurement science, standards, and calibration that is relevant to laboratory quality. The laboratory should have documented procedures for instrument calibration, reagent handling, and data management.

The quality system should include internal quality controls, such as positive and negative controls, that are run with each batch of samples. The controls should be tested with both the new assay and the reference method to ensure that the methods are performing correctly.

The quality system should also include external quality assessment, such as participation in proficiency testing programs. Proficiency testing provides an independent assessment of the laboratory's performance and can identify systematic errors that are not apparent from internal controls.

Biosafety and Regulatory Context

The concordance analysis may involve the use of biological samples that pose a risk to laboratory workers. The Biosafety in Microbiological and Biomedical Laboratories manual provides principles for biosafety, risk assessment, and containment. The laboratory should conduct a risk assessment before beginning the validation and should follow the appropriate biosafety level for the samples being tested.

The risk assessment should consider the nature of the samples, the procedures being performed, and the potential for exposure. The laboratory should implement the appropriate containment measures, including personal protective equipment, engineering controls, and administrative controls.

If the assay involves recombinant or synthetic nucleic acid molecules, the laboratory should follow the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. These guidelines provide oversight for research involving these molecules and should be followed when applicable.

The laboratory should also follow the protocols for the specific assay being validated. The Addgene protocols provide educational context for molecular biology workflows, but they should not be treated as universally validated protocols. The laboratory should validate the specific protocol for its own conditions.

Reporting and Documentation Standards

The reporting of a concordance analysis should follow the standards for transparency and completeness. The MIQE guidelines provide a framework for reporting qPCR experiments, and the principles of transparency and completeness apply to concordance analysis as well.

The report should include the following elements:

• The purpose of the validation
• The description of the new assay and the reference method
• The sample description, including the sample source and the sample size
• The contingency table
• The statistical calculations, including the kappa value, the confidence interval, and the McNemar's test result
• The discordance analysis
• The interpretation of the results
• The limitations of the analysis

The report should be written in a way that allows another scientist to understand the analysis and to reproduce it if necessary. The report should be stored in the laboratory quality system and should be available for inspection by regulatory authorities or accreditation bodies.

Frequently Asked Questions

What is the difference between Cohen's kappa and McNemar's test?

Cohen's kappa measures the magnitude of agreement between two methods, while McNemar's test measures the direction of disagreement. Kappa tells you how much agreement exists beyond chance, and McNemar's test tells you whether the disagreement is systematic.

When should I use weighted kappa instead of Cohen's kappa?

Use weighted kappa when your assay categories have a natural order, such as negative, equivocal, and positive. Weighted kappa assigns different weights to different types of disagreement, so a disagreement between negative and positive is penalized more than a disagreement between negative and equivocal.

How do I choose the weighting scheme for weighted kappa?

The weighting scheme should be chosen before data collection and documented in the validation protocol. Linear weights and quadratic weights are common choices. The choice should reflect the analytical importance of the different types of disagreement.

What is a good kappa value for a qualitative assay?

The acceptable kappa value depends on the purpose of the assay and the consequences of a wrong result. A kappa value above 0.80 is generally considered almost perfect agreement, but the acceptance criterion should be defined in the validation protocol before data collection.

Can I use kappa to compare more than two methods?

Kappa is designed for two methods. If you need to compare more than two methods, you should use a different approach, such as Fleiss' kappa, which is an extension of Cohen's kappa for multiple raters.

What is the effect of sample size on the kappa value?

A small sample size produces a kappa estimate with a wide confidence interval. The point estimate may be accurate, but the confidence interval will be too wide to draw a meaningful conclusion. The sample size should be calculated during the protocol development phase.

How do I interpret a significant McNemar's test?

A significant McNemar's test indicates that the disagreement between the two methods is not symmetric. One method is more likely to produce a particular result than the other. This suggests a systematic bias that should be investigated.

Can I use kappa for a quantitative assay that is dichotomized?

Yes, but the kappa value will depend on the threshold used to dichotomize the continuous result. The threshold should be chosen before data collection and documented in the validation protocol.

Related Diagnostic Guides

• Cell Viability Assays: Choosing the Right Method for Your Experiment
• Serology Tests Explained: What They Detect and How to Interpret Results
• Cell Migration Assays: Transwell vs. Wound Healing
• Method Validation in Clinical Laboratories: A Practical Protocol

References and Further Reading

• Molecular Biology and Laboratory Methods. National Library of Medicine.
• Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
• NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. National Institutes of Health.
• Addgene Protocols. Addgene.
• MIQE Guidelines. Clinical Chemistry.
• NIST Laboratory Programs. National Institute of Standards and Technology.
• Laboratory Biosafety Manual. World Health Organization.
• NCBI Literature Resources. National Center for Biotechnology Information.
• Multicenter clinical evaluation of a novel transcription-mediated amplification assay for SARS-CoV-2 molecular testing.. Enfermedades infecciosas y microbiologia clinica, 2022.
• Rapid and qualitative identification of SARS-CoV-2 mutations associated with variants of concern using a multiplex RT-PCR assay coupled with melting analysis.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022.
• Performance analysis of the GeneXpert respiratory panel prototype assay for the diagnosis of viral and bacterial upper respiratory tract infections.. Microbiology spectrum, 2025.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.